0
     

Report Added
Report already added
Dermatologicals in the Czech Republic

Dermatologicals in the Czech Republic

The stress related to COVID-19 and, more recently, to high energy and commodity price hikes is causing multiple scalp problems amongst a larger number of Czech consumers. Such conditions can be highly irritating and distressing, forcing consumers to medicate to alleviate their symptoms. This is leading to a surge in demand for medicated shampoos (that specifically treat itchy scalps and dandruff). Furthermore, mild to severe hair loss has been reported as one of the post-COVID-19 symptoms, trigg...

Euromonitor International's Dermatologicals in Czech Republic report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Dermatologicals in the Czech Republic

List Of Contents And Tables

DERMATOLOGICALS IN THE CZECH REPUBLIC
KEY DATA FINDINGS
2022 DEVELOPMENTS
Medicated shampoos, hair loss treatments and paediatric treatments continue to gain momentum in the post-pandemic landscape
Sales values/volumes of antifungals remain below pre-pandemic levels despite return to sports centres, swimming pools and international travel
E-commerce sales grow as consumers value anonymity for embarrassing purchases
PROSPECTS AND OPPORTUNITIES
More players set to enter category thanks to potential of hair loss treatments
Private label set to gain value share as players invest in dermatologicals portfolio
Increasing prevalence of herbal products and products containing CBD
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2017-2022
Table 2 Sales of Dermatologicals by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Dermatologicals: % Value 2018-2022
Table 4 LBN Brand Shares of Dermatologicals: % Value 2019-2022
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
Table 6 Forecast Sales of Dermatologicals by Category: Value 2022-2027
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN THE CZECH REPUBLIC
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 9 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2017-2022
Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format: % Value 2017-2022
Table 16 Distribution of Consumer Health by Format and Category: % Value 2022
Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources

Report Title: Dermatologicals in the Czech Republic


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW